ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro
  adhoc with the aim of a Europe-wide distribution. The issuer is solely
  responsible for the content of this announcement.

9-month report

09.11.2009

Given the 9-month figures and a current outlook based on the October 
figures stock listed medical device manufacturer W.O.M. WORLD OF 
MEDICINE AG anticipates that this year`s development after the first 
nine months will also be carried forward in the fourth quarter 2009. 
This implies a reduction in sales for the year 2009 as a whole of 
approximately 15%, with a return on sales before taxes of 3%. This 
takes into account the weakening of the US dollar. The previous 
outlook expected sales at the level as 2008 and a return on sales 
before taxes of 6%.

Especially US sales were lower than expected. In the end of the 3rd 
quarter 2009, a slight increase in the volume of orders booked 
indicates tentative signs of recovery in the region. However, the 
sustainability of these signs and the pace at which a potential shift
in trends is established by WORLD OF MEDICINE`s sales are still 
placed in question.

The complete 9-Month Report 2009 is available on November 10, 2009, 
8.00 a.m. CET, at the following link:

www.world-of-medicine.com/wsc/pdf/wom/en/qr_9monthreport_2009_wom.pdf
 

The Management Board

end of announcement                               euro adhoc

Further inquiry note:

Stefanie Gehrke
Cell Phone: + 49 (0) 172 402 67 40
E-Mail: stefanie.gehrke@womcorp.com

Branche: Pharmaceuticals
ISIN: DE0006637390
WKN: 663739
Index: CDAX, Prime All Share, Technologie All Share
Börsen: Frankfurt / regulated dealing/prime standard
Berlin / free trade
Hamburg / free trade
Stuttgart / free trade
Düsseldorf / free trade
München / free trade